Your continuous glucose monitor shows you exactly how white bread affects your blood sugar, but tells you almost nothing about how that "healthy" smoothie is quietly filling your liver with fat. While CGMs have revolutionised our understanding of glucose responses, they miss the parallel fructose pathway that drives visceral fat accumulation without spiking blood sugar. Here's why the sugar your monitor can't see might be doing the most metabolic damage.
Your continuous glucose monitor shows exactly how bread affects blood sugar but misses the fructose pathway completely. While CGMs track glucose perfectly, they remain blind to fructose heading straight to your liver, where it converts to triglycerides and visceral fat without spiking blood glucose.
Sarah checks her continuous glucose monitor religiously. She's learned that white bread sends her blood sugar soaring, while her morning smoothie packed with berries and banana barely registers a blip. Based on her CGM readings, she's confident the smoothie is the healthier choice. But Sarah's monitor is telling her less than half the story.
The problem lies in what CGMs don't measure. While these devices excel at tracking glucose, they remain completely blind to fructose, a sugar that follows an entirely different metabolic pathway [2]. Think of glucose and fructose as two different delivery trucks heading to separate warehouses in your body. Glucose heads primarily to muscle cells, where it either gets burned for energy or stored as glycogen. Your CGM tracks this journey beautifully. Fructose, however, takes a direct route to the liver, where it gets processed into fat without triggering the same insulin response that glucose does [2,7].
This explains why Sarah's fruit smoothie appears metabolically innocent on her monitor. The fructose from those berries and banana is bypassing her bloodstream's glucose highway entirely, heading straight to her liver where it's quietly being converted to triglycerides and contributing to visceral fat accumulation [3,7]. Her CGM sees the small amount of glucose from the fruit, but the fructose load remains invisible.
This metabolic blind spot affects millions of health-conscious people who rely on CGMs to guide their food choices. They're optimising for glucose control while unknowingly overwhelming their livers with fructose, setting themselves up for fatty liver disease, elevated triglycerides, and the gradual accumulation of visceral adipose tissue that drives cardiometabolic disease [4,6].
To understand why your CGM misses the fructose story, imagine your body's sugar processing system as a busy city with two completely separate highway networks. The glucose highway is well-monitored, with traffic cameras everywhere reporting back to your CGM. The fructose highway runs parallel but underground, processing enormous amounts of traffic with virtually no external monitoring.
When you eat table sugar, which is exactly half glucose and half fructose, you're sending equal amounts of traffic down both highways [1]. Your CGM will dutifully report the glucose traffic, showing you a blood sugar spike that typically peaks around 30 to 60 minutes after eating. Meanwhile, the fructose portion heads directly to your liver via the portal circulation, where it gets metabolised through a completely different set of enzymes [2,7].
Here's where the metabolic consequences diverge dramatically. Glucose metabolism is tightly regulated by insulin, which acts like a sophisticated traffic control system, directing glucose into muscle cells when they need energy and storing excess as glycogen [12]. Fructose metabolism, by contrast, operates more like an unregulated highway with no speed limits [2]. The liver processes fructose as quickly as it arrives, converting excess directly into fat through a process called de novo lipogenesis [7,10].
This fundamental difference explains why two foods with identical carbohydrate content can have vastly different metabolic effects [2]. A potato contains mostly glucose and starch, creating a large CGM spike but relatively little liver burden. A serving of fruit containing the same amount of total carbohydrate might show a modest CGM response while delivering a substantial fructose load that your liver must process into triglycerides [3,9].
In the UK, where we measure blood glucose in mmol/L, a typical post-meal spike might reach 10-12 mmol/L after glucose-rich foods. In the USA, using mg/dL, the same response appears as 180-216 mg/dL. But regardless of which units you use, these measurements tell you nothing about the fructose pathway operating simultaneously.
Understanding the fructose blind spot doesn't mean abandoning your CGM or avoiding all fruit. Instead, it means using your glucose monitor as one tool among several for optimising metabolic health.
The fructose pathway represents one of the most direct routes from dietary choices to visceral adipose tissue accumulation [3]. Unlike glucose, which gets distributed throughout the body's tissues, fructose concentrates its metabolic effects in the liver, where excess gets converted to the very triglycerides that fill VLDL particles and contribute to visceral fat deposits [7,9].
This process directly impacts three of the four pillars simultaneously. Pillar 2 suffers as the liver packages newly-created triglycerides into ApoB-containing VLDL particles, increasing cardiovascular risk [3,9]. Pillar 3 becomes compromised as fatty liver development leads to insulin resistance, making glucose control more difficult over time [4,6]. Pillar 4, visceral fat accumulation, increases as the metabolic dysfunction spreads beyond the liver to visceral adipose deposits throughout the abdomen [3].
Your CGM's focus on glucose means it's primarily monitoring Pillar 3 while remaining blind to the processes that drive Pillars 2 and 4. This explains why people can achieve excellent glucose control while still developing fatty liver, elevated triglycerides, and expanding visceral fat deposits [4,6]. The fructose pathway operates as a parallel system of metabolic damage that glucose monitoring alone cannot detect or prevent [2,7].
Continuous glucose monitors track glucose metabolism but remain completely blind to fructose, which follows a separate pathway directly to the liver.
Fructose gets converted to triglycerides and visceral fat without creating the blood sugar spikes that would warn you through your CGM.
Monitoring fasting triglycerides every few months provides insight into your liver's fructose processing burden that CGMs cannot detect.
Choosing lower-fructose fruits and timing fruit consumption around exercise helps minimise the hidden metabolic load your glucose monitor misses.
1. Lustig RH, Schmidt LA, Brindis CD. Public health: The toxic truth about sugar. Nature. 2012;482(7383):27-29. doi:10.1038/482027a
2. Tappy L, Lê KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010;90(1):23-46. doi:10.1152/physrev.00019.2009
3. Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119(5):1322-1334. doi:10.1172/JCI37385
4. Jensen T, Abdelmalek MF, Sullivan S, et al. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018;68(5):1063-1075. doi:10.1016/j.jhep.2018.01.019
5. Lanaspa MA, Sanchez-Lozada LG, Roncal-Jimenez C, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2011;286(52):44358-44366. doi:10.1074/jbc.M111.285114
6. DiNicolantonio JJ, O'Keefe JH, Lucan SC. Added fructose: a principal driver of type 2 diabetes mellitus and its consequences. Mayo Clin Proc. 2015;90(3):372-381. doi:10.1016/j.mayocp.2014.12.019
7. Ter Horst KW, Serlie MJ. Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease. Nutrients. 2017;9(9):981. doi:10.3390/nu9090981
8. Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006;290(3):F625-F631. doi:10.1152/ajprenal.00140.2005
9. Le KA, Ith M, Kreis R, et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr. 2009;89(6):1760-1765. doi:10.3945/ajcn.2008.27336
10. Schwarz JM, Noworolski SM, Wen MJ, et al. Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat. J Clin Endocrinol Metab. 2015;100(6):2434-2442. doi:10.1210/jc.2014-3678
11. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79(4):537-543. doi:10.1093/ajcn/79.4.537
12. Havel PJ. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev. 2005;63(5):133-157. doi:10.1111/j.1753-4887.2005.tb00132.x
Read the plain-text blog post — accessible in multiple languages via auto-translate — at https://www.vat-trap.com/post/cgm-fructose-blind-spot
🎧 Prefer to listen? A Google NotebookLM audio podcast version may be available as a story on the blog post above. Check the blog post for the podcast player.
This referenced version is published in UK English only and is not auto-translated. Read the translated blog post →